08.01.25 August monthly MDL report: More than 2,000 active cases The number of active claims in the MDL grew past 2,000, marking 2,190 active GLP-1 lawsuits, including Wegovy claims
doi:10.3389/fphar.2023.1254382
Deng Y, Li W, Zhang Y, Li J, He F, Dong K et al (2023) -linolenic acid inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation in vivo
This varies dramatically by peptide and by the aspect of disease being targeted: Anti-inflammatory effects (KPV, BPC-157): Often noticeable within days to 2 weeks Gut healing (BPC-157, KPV): Initial improvements in 1-2 weeks, more substantial healing over 4-8 weeks Immune rebalancing (thymosin alpha-1): Treg expansion takes weeks to months
What You Should Know: Nestl Health Science, a global leader in nutritional science, today announced the launch of glp-1nutrition.com, a web platform designed to support individuals on their weight management journey, particularly those using GLP-1 medications
1.2g/kg (0.54g/lb) is the lower bound supported by the literature for lean-mass preservation in weight loss, as summarised in a 2016 review in Nutrition Reviews (Cava et al., 2017, Nutrition Reviews)
